Company profile: Aignostics
1.1 - Company Overview
Company description
- Provider of AI-powered precision diagnostics in pathology for drug development and clinical research, using patented explainable AI to overcome black-box limitations. Services include research turning biomedical data into insights, GxP-compliant AI models for clinical trials, certified CDx for central labs and partners, and end-to-end prediction models from image and multi-modal data.
Products and services
- Clinical Trials: Develops GxP-compliant models for trial deployment, collaborating with pathologists and regulatory experts to ensure pathology-focused evaluation and regulatory-ready workflows
- CDx & Clinical Routine: Certifies AI models for companion diagnostics (CDx), deployed in central labs and partner institutions for routine pathology workflows
- End-to-end Prediction Models: Delivers explainable-AI-driven models that predict molecular or clinical parameters from image or multi-modal data, using Explainable AI for feature derivation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aignostics
HelloBetter
HQ: Germany
Website
- Description: Provider of digital therapeutics (DTx) and prescription digital therapeutics (PDTx) for mental health, offering 10 DTx and 6 PDTx with universal reimbursement for 73m+ people and 33 clinical studies; founded as a university spin-off in 2015.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HelloBetter company profile →
inHEART
HQ: France
Website
- Description: Provider of cloud-based, AI-enabled medical image analysis and cardiac modeling solutions for heart rhythm disorders, delivering a digital twin of the heart for image-guided diagnosis and therapy planning. Offers inHEART MODELS for 3D visualization and analysis to guide cardiac ablations and personalized treatment planning, and an AI software module for automated segmentation to generate detailed 3D cardiac models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full inHEART company profile →
Ritten
HQ: United States
Website
- Description: Provider of a software platform for behavioral health facilities, including automated billing and claims, compliance tracking with to-do lists, scheduling for individual and group sessions, a HIPAA-compliant patient portal for assessments, intake and document sharing, medication management with DoseSpot ePrescribing integration, and customizable form building.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ritten company profile →
Hippocratic AI
HQ: United States
Website
- Description: Provider of safety-focused healthcare large language models and generative AI agents for non-diagnostic, patient-facing applications, including Polaris specialized LLMs for accurate medical reasoning and natural patient conversations; voice-optimized agents; and tools for lab reference ranges, longitudinal lab analysis, lab/medication interactions, and prescription adherence.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hippocratic AI company profile →
Cognetivity
HQ: United States
Website
- Description: Provider of an AI medical technology platform for early, rapid and easy detection of cognitive impairment, dementia and Alzheimer’s disease, offering CognICA, a digital tool that measures cognitive function using AI analysis of a rapid visual categorization test, and OptiMind, a smartphone app for measuring and tracking cognitive performance with lifestyle recommendations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cognetivity company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aignostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aignostics
2.2 - Growth funds investing in similar companies to Aignostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aignostics
4.2 - Public trading comparable groups for Aignostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →